Linfoma no Hodgkin en pacientes pediátricos
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Abstract
In pediatric non-Hodgkin lymphoma (NHL), early initiation of chemotherapy is of utmost importance for prognosis. This study aims to determine the frequency of NHL presentation in our setting and the probability of response to the chemotherapeutic treatment used at that time.
A retrospective analysis was conducted of 57 patients diagnosed with NHL at SOLCA, Guayaquil, between 1980 and 1990. Ten patients who did not receive treatment after abandoning medical care following diagnosis were excluded from the treatment analysis. However, they were included in the analysis of age, sex, stage, histopathological classification, and symptoms.
Sixty-eight percent of the patients were lost to follow-up after discontinuing treatment. Thirteen percent died from infection during chemotherapy, and 19 % of the children remained disease-free until the end of the study.
Downloads
References
Armitage JO, Coleman M, Connors JM, Fisher RI, Kline JP, Skarin AT. Non-Hodgkin's lymphoma: chemotherapy for the 1990s.
White L, Siegel SE. Non-Hodgkin's lymphoma in childhood. In: Clinical Pediatric Oncology. 3rd ed. Chapter 20.
Escudero A, Rivas MC, Sánchez Guilarte J, Bosch JM, Rodríguez Centella C. Linfomas no hodgkinianos. En: Tratado de Medicina Interna. 5.ª ed. Idepsa Internacional de Ediciones y Publicaciones; mayo de 1988.
Hannon Eyre, MD; Farver Max, MD. Hodgkin's disease and non-Hodgkin's lymphomas. Chapter 28. In: American Cancer Society Textbook of Clinical Oncology.
Miescher P, Jaffe E. Advances in chemotherapy for Hodgkin's lymphoma. Seminars in Hematology. 1988;25(2 Suppl 2).
Sierrasesúmaga L, Calvo F, Villa-Elizaga I, Cañadel J. Oncología pediátrica. Interamericana de España; 1992.
Sutow WW, Fernbach DJ, Vietti TJ. Clinical Pediatric Oncology. 3rd ed.; 1984.
